Multiple sclerosis and intrathecal IgA synthesis. 1997

A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
Laboratorio de Neuroquimica, Centro de Diagnostico Computorizado, Lisboa, Portugal.

A clinically definite diagnosis of multiple sclerosis was done in a 61 year-old woman who displayed severe cerebellar and pyramidal tract involvement. Symptoms developed 5 years before with unsteadiness of gait and difficulties in walking. Diagnosis was supported by evoked potentials studies and magnetic resonance imaging. However, the cerebrospinal fluid (CSF) analysis was very unusual. CSF albumin and IgG concentrations were normal, as well as the IgG index. In contrast, the IgA level and the IgA index were markedly increased and the local synthesis of IgA was estimated at 31.36 mg/l. Reduction by dithiotreitol did not change the IgA level. On affinity immunoblots, oligoclonal IgA bands were not detected but oligoclonal IgG bands were present. The strong local production of IgA in this patient seems to be therefore polyclonal.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D004226 Dithioerythritol A compound that, along with its isomer, Cleland's reagent (DITHIOTHREITOL), is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups. 2,3-Dihydroxy-1,4-dithiolbutane,Dithioerythreitol
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005073 Evoked Potentials, Somatosensory The electric response evoked in the CEREBRAL CORTEX by stimulation along AFFERENT PATHWAYS from PERIPHERAL NERVES to CEREBRUM. Somatosensory Evoked Potentials,Evoked Potential, Somatosensory,Somatosensory Evoked Potential
D005074 Evoked Potentials, Visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. Visual Evoked Response,Evoked Potential, Visual,Evoked Response, Visual,Evoked Responses, Visual,Potential, Visual Evoked,Potentials, Visual Evoked,Response, Visual Evoked,Responses, Visual Evoked,Visual Evoked Potential,Visual Evoked Potentials,Visual Evoked Responses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
March 2022, Scientific reports,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
September 1989, Acta neurologica Scandinavica,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
March 1976, Lancet (London, England),
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
September 2013, Journal of neuroimmunology,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
February 1987, Acta neurologica Scandinavica,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
November 1991, Acta neurologica Scandinavica,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
January 2014, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
January 2005, Journal of the neurological sciences,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
August 2000, Journal of neuroimmunology,
A Sena, and P Rosado, and V Ferret-Sena, and J Coimbra, and E Schuller, and C J Sindic
November 1995, European journal of neurology,
Copied contents to your clipboard!